Autologous hematopoietic transplantation following COVID‐19 infection

Autologous hematopoietic transplantation following COVID‐19 infection

Abstract Autologous hematopoietic cell transplantation following induction therapy is standard of care for most patients with newly diagnosed multiple myeloma (N Engl J Med 2017, 376; 1311). Though active COVID‐19 infection is typically a contraindication to aggressive therapy, little is known about...

Full description

Bibliographic Details
Main Authors: Marthilde Brzycki, Robert Richard, Nicholas Burwick, Solomon Graf, Craig O'Brien, Daniel Wu, Thomas R. Chauncey
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:Clinical Case Reports
Subjects:
autologous transplantation
COVID‐19
multiple myeloma
Online Access:https://doi.org/10.1002/ccr3.3712

Internet

https://doi.org/10.1002/ccr3.3712

Similar Items